This inventor holds 1 USPTO granted patent and 1 published patent application and 4 EPO patents. Top assignee: Novartis Ag. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Daniel Robert Roth
Introduction: Daniel Robert Roth, an accomplished inventor based in Courroux, Switzerland, has made significant advancements in the field of renal health. With a keen focus on innovative methods for assessing kidney damage, Roth's work continues to impact the medical community.
Latest Patents: Roth holds a patent titled "Use of β-2-microglobulin to assess glomerular alterations and damage in the kidney." This invention is pivotal as it provides a method for measuring β-2-microglobulin to evaluate glomerular alterations or damage in the kidney, thus offering new avenues for diagnosing renal conditions.
Career Highlights: Presently, Daniel is associated with Novartis AG, a prominent player in the pharmaceutical industry. His role at Novartis has allowed him to leverage his expertise in nephrology and contribute to groundbreaking research.
Collaborations: Throughout his career, Roth has collaborated with esteemed colleagues such as Gerard Maurer and Frank Dieterle. These collaborations have fostered a rich environment of shared knowledge and innovation, leading to advancements in kidney health diagnostics.
Conclusion: Daniel Robert Roth's dedication to improving kidney health through innovative assessment methods is commendable. His invention not only underscores his ingenuity as an inventor but also highlights the importance of collaboration in fostering advancements within the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile